Thursday, March 05, 2026

Why do we sometimes experience a memory lapse? Science has found the explanation

 Imagine suddenly forgetting what you were about to say. This jarring experience of “mental blackout” happens to everyone at some point. Neuroscientists have recently uncovered some of the mysteries behind this phenomenon, which takes up as much as 20% of our waking hours. So what really happens in our brain during these blank moments?

The “memory lapse” when your mind goes completely blank, is something we all experience. However, this phenomenon remained largely unexplored scientifically until recently. A comprehensive analysis of 80 studies published in Trends in Cognitive  Sciences now offers new insights into the brain mechanisms involved when our thoughts seem to disappear. This research not only explains why we experience these mental disconnections, but also why some people are more prone to them than others. 

Local sleep: when parts of the brain fall asleep

Contrary to popular belief, mental blackouts aren’t just about losing focus. Electroencephalograms (EEGs) show something surprising: during these episodes, certain areas of the brain enter a state similar to sleep, producing slow-wave brain activity, even though the person is still fully awake.

This “local sleep” helps explain why mental blackouts often happen when we’re extremely tired. Researchers have identified several conditions that make memory lapses more likely, such as:

  • prolonged attention spans
  • lack of sleep
  • physical exhaustion
  • extreme fluctuations in brain excitation (either very high or low)

Brain imaging confirms these findings by showing a marked deactivation of areas linked to language, movement, and memory. This aligns perfectly with the symptoms people experience: a temporary inability to form coherent thoughts or recall familiar facts.

Individual differences in “mind blanking” episodes

On average, we spend between 5% and 20% of our time with a “blank mind,” but this varies greatly from person to person. Research shows that people with ADHD (Attention Deficit Hyperactivity Disorder) tend to experience mental blackouts more often than neurotypical individuals.

This variation stems from differences in how the brain regulates excitation levels. Researchers point out that it’s important to differentiate between mental blackouts and simple daydreaming. Daydreaming involves vague but present thoughts, while a memory lapse is the near-total absence of conscious mental activity.

Some of the most common signs of mental blanking include:

  1. Sudden interruptions in inner dialogue
  2. Lapses in attention during conversations
  3. Inability to recall familiar information
  4. Losing your train of thought during an activity

The triggers of mental blankness

Scientists believe that mental blackouts occur because of fluctuations in brain excitation levels. These changes lead to temporary malfunctions in cognitive systems like short-term memory, language processing, and sustained attention.

These episodes typically happen in two scenarios: after intense focus (like during a long exam) or during extreme fatigue. This suggests the brain has an “optimal zone” for functioning, and going beyond it increases the risk of disconnection.

The physiological, neuronal, and cognitive changes behind this explain why we sometimes find ourselves “lost for words” or unable to recall what we were doing. Understanding this opens up exciting new areas of research in cognitive neuroscience to better pinpoint the critical thresholds where our consciousness seems to vanish for a moment.

These findings about memory lapses reveal just how fragile our consciousness can be. It’s an ability we often take for granted, but it turns out to be more intermittent than we think.

 

 

This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   

Labels: , , , , ,

posted by G S Iyer at 9:23 AM 0 comments

What if your nights revealed ALS years in advance?

Researchers at Inserm have taken a significant step forward in understanding Amyotrophic Lateral Sclerosis, also known as Charcot disease, offering hope for a new therapeutic strategy to slow its progression. Their work highlights the role of the hypothalamus and reveals that sleep disturbances may appear long before motor symptoms develop. Even more promising, a molecule that restored sleep in mice helped preserve motor neurons. 

According to the French research team, sleep disorders precede the onset of motor symptoms in ALS. Could treating sleep disturbances help slow the disease? That is precisely what scientists observed in animal models. 

To date, there is no cure for ALS, a neurodegenerative disease that typically leads to death within three to five years of symptom onset. ALS is characterized by the progressive death of nerve cells known as motor neurons. As these cells degenerate, patients experience rapid and progressive muscle atrophy, motor impairments, and loss of independence. Ultimately, damage to the respiratory muscles leads to death. 

As with several other neurodegenerative conditions, researchers from Inserm and the University of Strasbourg wondered whether sleep disorders, often viewed as a consequence of disease progression, might actually precede motor decline. They also questioned whether restoring sleep could slow the disease’s course. 

To explore this, the team analyzed dozens of sleep recordings from groups of people living with ALS at different stages. One group had not yet developed respiratory symptoms. Another carried genetic mutations that increased their risk of developing the disease. Their results were compared with control groups.

The hypothalamus involved in sleep disturbances

“These tests indicate that both groups of individuals experienced the same type of sleep disturbances: increased wakefulness and reduced deep sleep compared with control groups,” the authors explained in a statement released on February 4. The findings, published in Science Translational Medicine, suggest that sleep disorders are present and detectable several years before motor symptoms emerge.

The researchers then looked for the origin of these disturbances in the brain. Their focus turned to orexin neurons, specialized cells in the hypothalamus known to regulate wakefulness. In mouse models of ALS that exhibited similar sleep abnormalities, the team discovered that the neural circuits involving these orexin neurons were altered. Supporting neurons within these circuits had disappeared as the disease progressed.

A promising molecule to slow disease progression

The scientists administered an orexin inhibitor, a drug already prescribed to treat insomnia, to the affected mice. The results were striking. After a single oral dose, the mice’s sleep was restored. Activity in the supporting neurons connected to orexin neurons also improved. After 15 days of treatment, preservation of motor neurons was observed in the mice.

The research team now hopes to test this molecule in patients with ALS. Could restoring sleep slow the progression of the disease?

“Our team’s discoveries are important on two levels,” explained Luc Dupuis, co senior author of the study. “First, they highlight a new timeline of ALS symptoms, once again questioning the origins of the disease, particularly the role of the brain in its development. They also offer a glimmer of hope for patients and those who may develop the disease, by suggesting that acting on its earliest manifestations could slow its extremely rapid progression.”

Did you know?

ALS affects approximately 8,000 people in France, according to the Association for ALS Research. Its annual incidence is 2.7 cases per 100,000 inhabitants. It is a rare neurodegenerative disorder marked by the destruction of motor neurons, the cells responsible for voluntary movement.

The disease typically appears between ages 50 and 70. ALS is progressive and usually leads to death within three to five years after the first signs. In most cases, failure of the respiratory muscles is the cause of death. In about 30 percent of cases, the disease begins with difficulty speaking or swallowing. In others, it starts with weakness or discomfort in an arm, leg, or hand.

Disease progression may include:

• muscle cramps and stiffness in muscles and joints;
• muscle wasting and coordination problems affecting walking, grasping objects, swallowing, or speaking;
• at an advanced stage, respiratory muscles can no longer function adequately.

These findings suggest that sleep, often overlooked in neurodegenerative diseases, may hold a key to understanding and potentially slowing ALS.

 

 

This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   

 

Labels: , , , ,

posted by G S Iyer at 9:14 AM 0 comments